XML 108 R65.htm IDEA: XBRL DOCUMENT v3.3.0.814
Employee Compensation and Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock Options Vesting
These awards had the following characteristics in common:
Type of Award
 
Percent of Options Awarded
 
Vesting Period
Service Condition:
 
 
 
 
Time-Based
 
25%
 
Ratably over four years (¼ on each of the four anniversaries of the grant date)
Market Condition:
 

 

Performance-Based
 
50
 
Over three years beginning with ¼ vesting on the date that the stock price has at least doubled over the exercise price and the compounded annual gain over the exercise price is at least 20% and then ratably over three years (¼ on the next three anniversaries of the achievement of the market condition)
Extraordinary Performance-Based
 
25
 
Over three years beginning with ¼ vesting on the date that the stock price has at least tripled over the exercise price and the compounded annual gain over the exercise price is at least 25% and then ratably over three years (¼ on the next three anniversaries of the achievement of the market condition)
Total award
 
100%
 
 
Schedule of Stock Option Activity
Stock option activity for the years ended December 31:
 
2014
 
2013
 
2012
 
Number of
Options
 
Weighted
Average
Exercise
Price
 
Number of
Options
 
Weighted
Average
Exercise
Price
 
Number of
Options
 
Weighted
Average
Exercise
Price
Outstanding at beginning of year
8,182,611

 
$
10.62

 
8,938,179

 
$
9.93

 
7,894,728

 
$
5.48

Granted (1)
330,000

 
$
34.48

 
50,000

 
$
51.70

 
2,160,000

 
$
23.92

Exercised (2)(3)
(683,750
)
 
$
8.30

 
(790,568
)
 
$
5.35

 
(1,116,549
)
 
$
3.56

Forfeited (1)
(1,000,000
)
 
$
24.38

 
(15,000
)
 
$
15.27

 

 
$

Outstanding at end of year (4)(5)
6,828,861

 
$
9.99

 
8,182,611

 
$
10.62

 
8,938,179

 
$
9.93

 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at end of year (4)(5)(6)
5,750,739

 
$
6.84

 
5,733,864

 
$
6.53

 
5,569,432

 
$
5.04

 
(1)
Stock options granted in 2012 include 2,000,000 options granted to Ocwen’s former Executive Chairman, William C. Erbey at an exercise price of $24.38 equal to the closing price of the stock on the day of the Committee’s approval. On April 22, 2014, Mr. Erbey surrendered 1,000,000 of these options. We recognized the remaining $5.7 million of previously unrecognized compensation expense associated with these options as of the date of surrender.
(2)
The total intrinsic value of stock options exercised, which is defined as the amount by which the market value of the stock on the date of exercise exceeds the exercise price, was $13.7 million, $35.3 million and $23.9 million for 2014, 2013 and 2012, respectively.
(3)
In connection with the exercise of stock options during 2014, 2013 and 2012, employees delivered 249,696, 138,553 and 33,605 shares, respectively, of common stock to Ocwen as payment for the exercise price and the income tax withholdings on the compensation. As a result, a total of 434,054, 652,015 and 1,082,944 net shares of stock were issued in 2014, 2013 and 2012, respectively, related to the exercise of stock options.
(4)
Excluding 295,000 market-based options that have not met their performance criteria, the net aggregate intrinsic value of stock options outstanding and stock options exercisable at December 31, 2014 was $41.1 million and $47.5 million, respectively. A total of 4,677,814 market-based options were outstanding at December 31, 2014, of which 3,986,878 were exercisable.
(5)
At December 31, 2014, the weighted average remaining contractual term of options outstanding and options exercisable was 4.47 years and 3.80 years, respectively.
(6)
The total fair value of the stock options that vested and became exercisable during 2014, 2013 and 2012, based on grant-date fair value, was $2.6 million, $4.7 million and $2.2 million, respectively.
Schedule of Assumptions used to Value Stock Option Awards Granted
The following assumptions were used to value stock option awards granted during the years ended December 31:
 
2014
 
2013
 
2012
 
Black-Scholes
 
Binomial
 
Black-Scholes
 
Binomial
 
Black-Scholes
 
Binomial
Risk-free interest rate
1.98% – 2.60%
 
0 - 3.05%
 
2.32%
 
0.24% - 3.56%
 
1.20% – 1.60%
 
0.70% – 3.06%
Expected stock price volatility (1)
42%
 
41% - 42%
 
44%
 
33% - 44%
 
40% – 42%
 
7% – 42%
Expected dividend yield
—%
 
—%
 
—%
 
—%
 
—%
 
—%
Expected option life (in years) (2)
6.50
 
4.35 - 5.64
 
6.50
 
4.50 - 5.75
 
6.50
 
4.50 – 6.50
Contractual life (in years)
 
10
 
 
10
 
 
10
Fair value
$11.93 - $17.01
 
$8.99 - $13.82
 
$24.32
 
$18.04 - $21.38
 
$6.49 – $10.48
 
$3.41 – $8.87
(1)
We estimate volatility based on the historical volatility of Ocwen’s common stock over the most recent period that corresponds with the estimated expected life of the option.
(2)
For the options valued using the Black-Scholes model we determined the expected life based on historical experience with similar awards, giving consideration to the contractual term, exercise patterns and post vesting forfeitures. The expected term of the options valued using the lattice (binomial) model is derived from the output of the model. The lattice (binomial) model incorporates exercise assumptions based on analysis of historical data. For all options, the expected life represents the period of time that options granted were expected to be outstanding at the date of the award.
Schedule of Equity-based Compensation Expense Related to Stock Options and Stock Awards and Related Excess Tax Benefit
The following table sets forth equity-based compensation related to stock options and stock awards and the related excess tax benefit for the years ended December 31:
 
2014
 
2013
 
2012
Equity-based compensation expense:
 
 
 
 
 
Stock option awards
$
9,983

 
$
5,388

 
$
2,776

Stock awards
746

 
260

 
158

Excess tax benefit related to share-based awards
6,374

 
21,244

 
11,031